Results 241 to 250 of about 378,571 (361)
Synthetic Patient-Physician Conversations Simulated by Large Language Models: A Multi-Dimensional Evaluation. [PDF]
Haider SA+10 more
europepmc +1 more source
EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche+8 more
wiley +1 more source
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner+6 more
wiley +1 more source
Pooling data for primary total knee implants across national registries: is the same implant used in multiple registries and for the same patient group? An observational study. [PDF]
Hoogervorst L+11 more
europepmc +1 more source
EL ERROR EN LA PERSONA DEL OTRO CÓNYUGE EN LA HISTORIA DEL DERECHO CANÓNICO
Carlos Salinas Araneda
openalex +1 more source
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul+11 more
wiley +1 more source
Journaling with large language models: a novel UX paradigm for AI-driven personal health management. [PDF]
Moëll B, Sand Aronsson F.
europepmc +1 more source
El uso de antidepresivos se asocia con mayor riesgo de fracturas de cadera en personas ancianas
José Ricardo Jáuregui
openalex +2 more sources
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva+5 more
wiley +1 more source